Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 70,000 shares of the stock in a transaction on Friday, May 8th. The shares were sold at an average price of $31.20, for a total value of $2,184,000.00. Following the sale, the chief executive officer directly owned 9,049,071 shares in the company, valued at $282,331,015.20. This trade represents a 0.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
K Charles Janac also recently made the following trade(s):
- On Wednesday, April 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $19.04, for a total value of $1,332,800.00.
- On Thursday, April 2nd, K Charles Janac sold 9,009 shares of Arteris stock. The shares were sold at an average price of $17.65, for a total value of $159,008.85.
- On Monday, April 6th, K Charles Janac sold 11,800 shares of Arteris stock. The shares were sold at an average price of $18.34, for a total value of $216,412.00.
- On Thursday, March 26th, K Charles Janac sold 32,988 shares of Arteris stock. The shares were sold at an average price of $18.35, for a total value of $605,329.80.
- On Wednesday, March 25th, K Charles Janac sold 7,012 shares of Arteris stock. The shares were sold at an average price of $18.03, for a total value of $126,426.36.
- On Tuesday, March 10th, K Charles Janac sold 9,000 shares of Arteris stock. The shares were sold at an average price of $14.66, for a total value of $131,940.00.
- On Monday, March 9th, K Charles Janac sold 41,000 shares of Arteris stock. The shares were sold at an average price of $14.21, for a total value of $582,610.00.
Arteris Stock Performance
AIP stock opened at $32.43 on Wednesday. Arteris, Inc. has a fifty-two week low of $6.88 and a fifty-two week high of $33.46. The business’s 50-day moving average is $20.37 and its two-hundred day moving average is $17.15. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -39.55 and a beta of 1.93.
Key Arteris News
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris posted a smaller-than-expected Q1 loss of $0.03 per share, beating the consensus loss estimate of $0.08 and improving from a $0.09 loss a year ago. Article Title
- Positive Sentiment: Revenue came in at $22.94 million, ahead of the $21.03 million estimate, showing stronger-than-expected demand and execution. Article Title
- Positive Sentiment: Management raised second-quarter and full-year revenue guidance, with Q2 sales expected at $23.0 million-$24.0 million and FY2026 revenue projected at $91.0 million-$95.0 million, both at or above analyst expectations. Article Title
- Neutral Sentiment: The company also released its earnings call transcript and investor materials, which may provide additional detail on growth drivers, margins, and customer momentum. Article Title
Institutional Trading of Arteris
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Roubaix Capital LLC bought a new stake in Arteris in the 3rd quarter worth approximately $2,361,000. Herald Investment Management Ltd increased its stake in Arteris by 33.3% in the 3rd quarter. Herald Investment Management Ltd now owns 400,000 shares of the company’s stock worth $4,036,000 after acquiring an additional 100,000 shares during the last quarter. Granahan Investment Management LLC increased its stake in Arteris by 725.7% in the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after acquiring an additional 546,341 shares during the last quarter. GSA Capital Partners LLP increased its stake in Arteris by 59.3% in the 3rd quarter. GSA Capital Partners LLP now owns 132,079 shares of the company’s stock worth $1,334,000 after acquiring an additional 49,153 shares during the last quarter. Finally, Huntleigh Advisors Inc. bought a new stake in Arteris in the 4th quarter worth approximately $1,832,000. Institutional investors own 64.36% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on AIP shares. Rosenblatt Securities reissued a “buy” rating and issued a $20.00 target price on shares of Arteris in a report on Friday, February 13th. Northland Securities set a $24.00 target price on Arteris in a report on Friday, February 13th. Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a report on Monday, April 20th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $20.17.
Read Our Latest Report on Arteris
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Arteris
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
